← FDA Drug Approvals (Drugs@FDA)
MIRABEGRON
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SAWAI USA · Approved 2025-05-06
Drug application
- FDA Application #
ANDA217061- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MIRABEGRON
- Generic name
- Mirabegron
- Active ingredients
- MIRABEGRON
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- SAWAI USA
- First approval
- 2025-05-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown